Strengthening Infection Prevention and Control and Systematic Surveillance of Healthcare Associated Infections in India

Overview

Journal BMJ

Specialty General Medicine

Date 2017 Sep 7

PMID 28874366

Citations 13

Authors

Soumya Swaminathan

Jagdish Prasad

Akshay C Dhariwal

Randeep Guleria

Mahesh C Misra

Rajesh Malhotra

Purva Mathur

Kamini Walia

Sunil Gupta

Aditya Sharma

Vinod Ohri

Sarika Jain

Neil Gupta

Kayla Laserson

Paul Malpiedi

Anoop Velayudhan

Benjamin Park

Padmini Srikantiah

Affiliations

Soon will be listed here.

Citing Articles

Surveillance of ventilator associated pneumonia in a network of indian hospitals using modified definitions: a pilot study.

Mathur P, Ningombam A, Soni K, Aggrawal R, Singh K, Samanta P Lancet Reg Health Southeast Asia. 2024; 28:100450.

PMID: 39130755 PMC: 11315213. DOI: 10.1016/j.lansea.2024.100450.

The challenges of implementing infection prevention and antimicrobial stewardship programs in resource-constrained settings.

Abbas S Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e45.

PMID: 38628374 PMC: 11019578. DOI: 10.1017/ash.2024.35.

The Pattern and Impact of Hospital-Acquired Infections and Its Outlook in India.

Thakkar J, Shanoo A, Gupta S, Thakkar A Cureus. 2023; 15(11):e48583.

PMID: 38090398 PMC: 10711345. DOI: 10.7759/cureus.48583.

Infection Control and Hygienic Measures Practiced Among Audiologists in India.

Sundaram C, Seethapathy J Indian J Otolaryngol Head Neck Surg. 2023; 74(Suppl 3):3541-3559.

PMID: 36742729 PMC: 9895510. DOI: 10.1007/s12070-020-01799-9.

Nosocomial Infections and Role of Nanotechnology.

Ananda T, Modi A, Chakraborty I, Managuli V, Mukhopadhyay C, Mazumder N Bioengineering (Basel). 2022; 9(2).

PMID: 35200404 PMC: 8869428. DOI: 10.3390/bioengineering9020051.

References

Mehta Y, Jaggi N, Rosenthal V, Kavathekar M, Sakle A, Munshi N . Device-Associated Infection Rates in 20 Cities of India, Data Summary for 2004-2013: Findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol. 2015; 37(2):172-81. DOI: 10.1017/ice.2015.276. View

Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin C . Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013; 173(22):2039-46. DOI: 10.1001/jamainternmed.2013.9763. View

Laxminarayan R, Duse A, Wattal C, Zaidi A, Wertheim H, Sumpradit N . Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013; 13(12):1057-98. DOI: 10.1016/S1473-3099(13)70318-9. View

Umscheid C, Mitchell M, Doshi J, Agarwal R, Williams K, Brennan P . Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011; 32(2):101-14. DOI: 10.1086/657912. View

Sodhi J, Satpathy S, Sharma D, Lodha R, Kapil A, Wadhwa N . Healthcare associated infections in Paediatric Intensive Care Unit of a tertiary care hospital in India: Hospital stay & extra costs. Indian J Med Res. 2016; 143(4):502-6. PMC: 4928558. DOI: 10.4103/0971-5916.184306. View

Kumar A, Biswal M, Dhaliwal N, Mahesh R, Appannanavar S, Gautam V . Point prevalence surveys of healthcare-associated infections and use of indwelling devices and antimicrobials over three years in a tertiary care hospital in India. J Hosp Infect. 2014; 86(4):272-4. DOI: 10.1016/j.jhin.2013.12.010. View

Mehta Y, Jaggi N, Rosenthal V, Rodrigues C, Todi S, Saini N . Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in 21 adult intensive-care units from 10 cities in India: findings of the International Nosocomial Infection Control Consortium (INICC). Epidemiol Infect. 2013; 141(12):2483-91. PMC: 9151371. DOI: 10.1017/S0950268813000381. View

Aiken A, Allegranzi B, Scott J, Mehtar S, Pittet D, Grundmann H . Antibiotic resistance needs global solutions. Lancet Infect Dis. 2014; 14(7):550-1. PMC: 6872450. DOI: 10.1016/S1473-3099(14)70709-1. View

Kamath S, Mallaya S, Shenoy S . Nosocomial infections in neonatal intensive care units: profile, risk factor assessment and antibiogram. Indian J Pediatr. 2010; 77(1):37-9. DOI: 10.1007/s12098-010-0005-5. View

10.

Allegranzi B, Pittet D . Healthcare-associated infection in developing countries: simple solutions to meet complex challenges. Infect Control Hosp Epidemiol. 2007; 28(12):1323-7. DOI: 10.1086/521656. View

11.

Weiner L, Webb A, Limbago B, Dudeck M, Patel J, Kallen A . Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol. 2016; 37(11):1288-1301. PMC: 6857725. DOI: 10.1017/ice.2016.174. View

12.

Mehrad B, Clark N, Zhanel G, Lynch 3rd J . Antimicrobial resistance in hospital-acquired gram-negative bacterial infections. Chest. 2015; 147(5):1413-1421. PMC: 4420185. DOI: 10.1378/chest.14-2171. View

13.

Holmes A, Moore L, Sundsfjord A, Steinbakk M, Regmi S, Karkey A . Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2015; 387(10014):176-87. DOI: 10.1016/S0140-6736(15)00473-0. View

14.

Pitout J, Nordmann P, Poirel L . Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance. Antimicrob Agents Chemother. 2015; 59(10):5873-84. PMC: 4576115. DOI: 10.1128/AAC.01019-15. View

15.

Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L . Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2010; 377(9761):228-41. DOI: 10.1016/S0140-6736(10)61458-4. View

16.

Rosenthal V . International Nosocomial Infection Control Consortium (INICC) resources: INICC multidimensional approach and INICC surveillance online system. Am J Infect Control. 2016; 44(6):e81-90. DOI: 10.1016/j.ajic.2016.01.005. View

17.

Biswal M, Mewara A, Appannanavar S, Taneja N . Mandatory public reporting of healthcare-associated infections in developed countries: how can developing countries follow?. J Hosp Infect. 2015; 90(1):12-4. DOI: 10.1016/j.jhin.2014.12.011. View

18.

Laxminarayan R, Heymann D . Challenges of drug resistance in the developing world. BMJ. 2012; 344:e1567. DOI: 10.1136/bmj.e1567. View

19.

Zaidi A, Huskins W, Thaver D, Bhutta Z, Abbas Z, Goldmann D . Hospital-acquired neonatal infections in developing countries. Lancet. 2005; 365(9465):1175-88. DOI: 10.1016/S0140-6736(05)71881-X. View

20.

Cardoso T, Almeida M, Carratala J, Aragao I, Costa-Pereira A, Sarmento A . Microbiology of healthcare-associated infections and the definition accuracy to predict infection by potentially drug resistant pathogens: a systematic review. BMC Infect Dis. 2015; 15:565. PMC: 4676854. DOI: 10.1186/s12879-015-1304-2. View